|Positive WB detected in||human plasma tissue|
|Western Blot (WB)||WB : 1:1000-1:4000|
|Sample-dependent, check data in validation data gallery|
66268-1-Ig targets C1qC in WB, ELISA applications and shows reactivity with human samples.
|Cited Reactivity||human, rat|
|Host / Isotype||Mouse / IgM|
|Immunogen||C1qC fusion protein Ag10233|
|Full Name||complement component 1, q subcomponent, C chain|
|Calculated molecular weight||245 aa, 26 kDa|
|Observed molecular weight||26 kDa|
|GenBank accession number||BC009016|
|Gene ID (NCBI)||714|
|Purification Method||Thiophilic affinity chromatograph|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
The first component of complement, C1, is a calcium-dependent complex of the 3 subcomponents C1q, C1r, and C1s. C1q is composed of 18 polypeptide chains: six A-chains, six B-chains, and six C-chains. Each chain contains a collagen-like region located near the N terminus and a C-terminal globular region. Deficiency of C1q has been associated with lupus erythematosus and glomerulonephritis. This antibody is raised against C1qC which is the C-chain polypeptide of human complement subcomponent C1q.
C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1.
Network pharmacology and experimental validation-based approach to understand the effect and mechanism of Taohong Siwu Decoction against ischemic stroke.
Onco Targets Ther
Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma.